Top Markets
Coin of the day
W World Corp. W World Corp.

W World Corp.

WWHC
Clasificación en acciones #22981
W World Corp. is a biopharmaceutical firm dedicated to identifying and... W World Corp. is a biopharmaceutical firm dedicated to identifying and advancing innovative treatments for various metabolic and neurological conditions. Its research and development efforts specifically target ailments related to the brain-gut axis, pain and inflammation, autoimmune diseases, and gout. The company's pipeline features two primary experimental drugs: Levotofisopam, currently in clinical trials as a non-sedative therapy for Gout, and Dextofisopam, a non-serotonergic compound that has successfully concluded Phase IIa and Phase IIb clinical trials for irritable bowel syndrome (IBS). Established in 1990, W World Corp. maintains its corporate headquarters in North Las Vegas, Nevada.
Precio por acción
$0.8
Última sincronización: 2024-01-02
Capitalización bursátil
$80.24M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio W World Corp. (WWHC)
Ratio P/B de W World Corp. (WWHC)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de W World Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de W World Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras